11 Things Women Are Told by Doctors About Menopause That the Evidence Now Contradicts
What stings most about this list is that these weren't things women read on a dubious wellness site — they were told to them by someone in a white coat. So many women have sat with unnecessary fear or needless suffering because the guidance didn't keep up with the science. Knowing this doesn't make anyone a bad patient for having believed it. It just means it's time for a reset.
Learn more about Rose →"HRT causes breast cancer" — stated as a flat fact
The blanket claim that hormone replacement therapy causes breast cancer traces back to a flawed reading of the 2002 Women's Health Initiative study, which used synthetic progestogen (medroxyprogesterone acetate) in older, already-cardiovascularly-compromised women. More recent analyses, including a 2019 Lancet re-examination, have clarified that the absolute risk increase for combined HRT is small — roughly equivalent to drinking one to two glasses of wine daily — and that oestrogen-only HRT shows no significant breast cancer increase. Women deserve that nuance, not a headline stripped of context.
"You're too young for menopause" when symptoms begin in the mid-40s
Perimenopause — the hormonal transition phase that precedes menopause — can begin anywhere from the late 30s to the mid-50s, and the average onset is around 47. Dismissing symptoms in a 44-year-old as unrelated to hormones because she's "too young" delays diagnosis and leaves real symptoms unaddressed, sometimes for years. The hormonal fluctuations of perimenopause are often more dramatic and disruptive than post-menopause itself.
"HRT is only safe for five years"
The five-year rule has no strong evidence base and is not supported by current guidance from the British Menopause Society, the Menopause Society (formerly NAMS), or the European Menopause and Andropause Society. It was a cautious, arbitrary threshold applied in the aftermath of the WHI panic, not a clinically derived limit. For many women, long-term HRT use is appropriate and the decision should be made individually based on ongoing risk-benefit assessment, not a calendar countdown.
"Your mood and memory issues are probably depression or stress, not hormones"
Oestrogen has well-documented effects on serotonin, dopamine, and acetylcholine — neurotransmitter systems central to mood regulation and cognitive function. Brain fog, low mood, irritability, and anxiety are recognised neurological symptoms of hormonal change, not simply life stress wearing a hormonal mask. Prescribing antidepressants without considering hormonal status first is a common and frustrating misstep that leaves the underlying cause untouched.
"Hot flushes are just uncomfortable — they don't affect your health"
Frequent, severe vasomotor symptoms are associated with measurable cardiovascular and bone health implications, not merely quality-of-life disruption. Research published in journals including Menopause and Circulation links moderate-to-severe hot flushes with increased markers of arterial stiffness and reduced bone density, particularly when left untreated over years. Treating them is not cosmetic — it is clinically relevant.
"Vaginal dryness is just a natural part of ageing — you'll have to live with it"
Genitourinary syndrome of menopause (GSM) — which encompasses vaginal dryness, atrophy, urinary urgency, and pain during sex — is a chronic, progressive condition that worsens without treatment, not something that stabilises on its own. Local vaginal oestrogen is highly effective, has minimal systemic absorption, and is considered safe even for most women with hormone-sensitive cancers by current oncology guidance. The idea that women should simply endure this is both outdated and unkind.
"Testosterone is not relevant for women"
Women produce testosterone throughout their reproductive lives, and levels decline significantly through perimenopause and menopause. There is a credible and growing body of evidence — including the Global Consensus Position Statement on Testosterone for Women — supporting its use for low libido and, emerging evidence suggests, for energy and cognitive function. Dismissing testosterone as "a male hormone" that has no place in women's care ignores basic endocrinology.
"Weight gain at menopause is just about eating too much and moving too little"
Oestrogen decline directly affects fat distribution, shifting storage away from the hips and thighs toward the abdomen — a pattern linked to increased metabolic and cardiovascular risk. Changes in insulin sensitivity, cortisol regulation, and sleep quality during perimenopause further complicate weight management in ways that standard calorie advice does not address. Telling women to simply "eat less" without acknowledging the hormonal substrate of this change is both inaccurate and demoralising.
"If you still have a period occasionally, you can't be in perimenopause"
Perimenopause is defined by hormonal variability, not by the absence of periods. Irregular cycles — including skipped cycles followed by normal ones — are a hallmark of the transition, not evidence that it hasn't started. FSH levels are also unreliable as a single diagnostic marker in perimenopause because oestrogen fluctuates so widely; a single normal FSH result is not a definitive reassurance.
"HRT will just delay your symptoms — they'll hit worse when you stop"
This claim, often used to discourage women from starting HRT, is not robustly supported by evidence. While some women do experience a return of symptoms after discontinuing HRT — particularly vasomotor symptoms — this is not universal, and symptoms generally return to what they would have been at that hormonal stage rather than rebounding worse. More importantly, for women still in the window of significant symptoms, it is not a valid reason to withhold effective treatment.
"There's no evidence that menopause affects sleep — try better sleep hygiene"
The relationship between hormonal change and sleep disruption is physiologically direct: night sweats interrupt sleep architecture, oestrogen decline affects thermoregulation, and progesterone — which has known sleep-promoting properties — drops sharply in perimenopause. Advising women to improve sleep hygiene without addressing the hormonal drivers is like recommending ear plugs to someone whose smoke alarm is going off. Evidence supports both HRT and, where appropriate, progesterone-specific approaches for sleep disruption in this group.
Want to go deeper?
Rose covers every symptom, supplement, and condition in full detail — evidence-graded and agenda-free.
Rose is a free, evidence-based reference built for women navigating perimenopause and menopause. No ads. No products to sell. No agenda. Just honest answers — because every woman in this season deserves a trusted friend who has done the research.